President’s Letter | September 2022
From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…
Blog - Melanoma360
09/27/2022
President’s Letter | September 2022
From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…
|
09/27/2022
AIM Welcomes Ann Garst Taylor as New Director of Community Engagement
By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…
|
09/16/2022
Bristol Myers Squibb Receives European Commission Approval for LAG-3-Blocking Antibody Combination, Opdualag , for the Treatment of Unresectable or Metastatic Melanoma with Tumor Cell PD-L1 Expression < 1%
(NEWS PROVIDED BY Bristol Myers Squibb, September 16, 2022, ) Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the…
|
09/13/2022
Spirituality and Cancer Care With Michael Eselun, BCC
When faced with a cancer diagnosis, some patients rely on their spirituality to cope and find meaning behind the experience.…
|
09/13/2022
ESMO: TIL therapy improves on Yervoy in melanoma trial
(NEWS PROVIDED BY Pharmaphorum, September 11, 2022, Phil Taylor) A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has…
|
09/12/2022
Regeneron Reports Fianlimab plus Libtayo Showed Above 60% Response Rate in Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors
(NEWS PROVIDED BY Regeneron Pharmaceuticals, Inc. Sep 12, 2022, 02:30 ET) Positive clinical data presented in a mini-oral session at ESMO…
|
09/11/2022
Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma
Neoadjuvant IO Boosts High-Risk Melanoma EFS Results from the phase 2 SWOG S1801 study show that for patients given pembrolizumab…
|
09/06/2022
Survivor Spotlight: Erich & Jenn Djordjevic
By Mara Klecker Note: Erich passed away on September 28th, 2022, the same week his story ran in our newsletter.…
|
09/06/2022
Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor
By Mara Klecker Bev Johnson figured the abnormal bleeding she was experiencing was a side effect of her IUD losing…
|
08/09/2022
The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author
When going through difficulty, many people turn to friends and family for support. But what happens when those people dismiss…
|
Recent Posts
May. 04, 2026
Melanoma Monday: Every Day. Everywhere.
Apr. 27, 2026
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
Apr. 19, 2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026
FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients
Apr. 07, 2026